MannKind Corp. (MNKD)
3.005
-0.08
(-2.75%)
USD |
NASDAQ |
May 18, 13:19
MannKind Research and Development Expense (Quarterly) : 17.23M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| United Therapeutics Corp. | 138.20M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| BioMarin Pharmaceutical, Inc. | 178.80M |
| Geron Corp. | 14.96M |
| Insmed, Inc. | 209.48M |